審稿意見(jiàn)修回_第1頁(yè)
審稿意見(jiàn)修回_第2頁(yè)
審稿意見(jiàn)修回_第3頁(yè)
審稿意見(jiàn)修回_第4頁(yè)
全文預(yù)覽已結(jié)束

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\REQUESTFORREVISIONFeb18201512:10PMRE:MD-D-15-00193,entitled"Majorperioperativecomplicationsinlaparoscopicspleen-preservingtotalgastrectomyforgastriccancer:perspectivesfromahigh-volumecenter"PleasesubmittherevisedmanuscriptviaEditorialManagerbyApr01201511:59PM.COMMENTSTOAUTHOR:Wereadwithinterestyoursubmission.Despitetheeaseofusingthemodeltopredictoutcomes,themodelneedsfurthervalidationandthisshouldbeclearlystatedasalimitationinthemanuscript.Moreover,whywastheNo.10LNmetastasisnotincludedinthemodeldespiteitsstatisticalsignificance?一點(diǎn)應(yīng)該在文章的“不足”部分更清晰的闡釋。另外,NO.10淋巴結(jié)轉(zhuǎn)移是影響CommentstoAuthorReviewer#1:TheinclusioncriteriaforLSPTGarefarbeyondtheJGCAguidelinesforgastriccancertreatment.Bynow,laparoscopicgastrectomyiswellacceptedamongearlydiseases.However,forlocallyadvancedgastriccancer,laparoscopicgastrectomyisonlyconsideredinaprospectiveinvestigation.Additionally,thereisnovalidationforapredictionmodelinthisstudy.Reviewer1:行腹腔鏡保脾淋巴清掃(LSPTG)JGCA的治療指文中的納入和排除標(biāo)準(zhǔn):Theinclusioncriteriawereasfollows:tumorshadtobelocatedintheuppertwo-thirdsofthestomachortheentirestomach;andpreoperativeevaluationsofthedepthoftumorinvasionhadtoshowthatthetumorwasconfinedtothemuscular(T2)orsubserosallayer(T3).Patientswithdistantmetastasesorobviousserosalcancerinvolvementatthetimeofpreoperativeexaminationwereexcludedfromthisstudy.Reviewer#2:Paperlookingattheperioperativecomplicationsassociatedwithsplenicpreservinglaparoscopictotalgastrectomyforcancerandaproposedscoringsystemforpredictionofmajorcomplications.SomeItisuncertainwhattheutilityofthescoringsystemis.Aretheauthorsproposingthatthesepatientsshouldnothavealaparoscopicprocedurebutanopen.Aretheyproposingthatthespleenshouldberemovedinthesepatients.clarificationwouldbeMostoftheconcernsregardingsplenicpreservationareoncologicalnottechnical.Thisremainscontroversialandiscurrentlyunderinvestigationwithresultsduesoon(ref4)TheabstractandintroductioninparticularshouldnotetheoncologicalissuesconcerningsplenicpreservationThesecondsentenceintheintroductioniscontroversialandnotbackedbyevidence.Itwouldbebettertonotethatmultimodalitytherapyisacceptedasthemosteffectivecurativetreatmentofwhichsurgeryisanessentialpart前言第二句“SurgicaltreatmentiswidelyacceptedasthemosteffectivestrategyforisacceptedasthemosteffectivecurativetreatmentofwhichsurgeryisanessentialItisnotedthatTstagingofthetumoursoccurredpreoperatively.AsEUSwasnotmentionedaspartoftheirpreoperativeworkup,howwasaccurateTstagingdeterminedpreoperatively.SimilarlyasT3tumourswereincludedinthestudy,didthesepatientshaveneoadjuventtherapypriortosurgeryandifsodidthisaffectoutcomeThereisnomentionofpreoperativelymphnodestaging.Werepatientswithpositivelymphnodes(bywhateverstagingcriteria)includedinthestudy.IfsodidtheyhaveneoadjuvanttherapyanddidthishaveanyinfluenceonoutcomeItisnotedthatpatientswere"allowedtoselect"thetypeofoperation.Wasthisopenvlaparoscopic,Wasitsplenicpreservinglaparoscopicvspleenremovedlaparoscopic.Thisneedstobeclarified保脾vs腹腔鏡切脾?Ifpatientshadopenorspleenremovedlaparoscopicprocedures,whatweretheirratesofcomplications.AlthoughitisstatedthatLNdissectionofstation10occurred,nowhereinthestudydoesitmentionthenumberoflymphnodesremvedfromthisstationwiththisWasthereanycorrelationbetweenthenumberoflymphnodesremovedandtheincidenceofcomplications.Thebaldstatementismadethatpatientspreferlaparoscopicsurgerybecauseofitsadvantages.WouldtheauthorspleaseoutlinetheseadvantageswithreferencesEditorialFormatting(格式要求-Titlepage:Besurethetitlepagelistsallauthornames,degrees,and-Title:Besurethetitleincludesanyspecifictermsasdirectedinthereportingguidelinesforyourtypeofarticle(forexample,"casereport"shouldbeinthetitleofaCARE-compliantarticle).Thefollowingguidelinesspecifytermsthatshouldbeinthetitle:CARE,CHEERS,CONSORT,PRISMA.-Abstract:Besuretouseastructuredabstract,withheadings.UsethespecificheadingslistedintheguidelineschecklistifyourreportisbasedontheCARE,CHEERS,CONSORT,orPRISMAguidelines.-Listofabbreviations:Ifnotalreadyincluded,pleaseincludealistofabbreviationsusedinthetextaspartofthemanuscripttextfilefollowingthetitlepage.Useabbreviationssparinglyinthetext,andspellthemoutthefirsttimeyouusethem.Abbreviationsusedintablesshouldbespelledoutatthebottomofthetable.-Ethicalreview,Methodssection:Ifnotalreadyincluded,pleasestateintheMethodssectionthatanethicscommitteeorinstitutionalreviewboardapprovedthestudy,andlisttheboard'sname.Ifethicalapprovalwaswaivedornotnecessary,pleasestatethereason.Ifthestudyinvolvespatientconsent,stateexplicitlythatinformedconsentwasorwasnotgiven,andstatethereasonifnotgiven.-Funding/ConflictofInterestinformation:ListanysourceoffundingoranythingthatcouldbeperceivedasaconflictofinterestintheAcknowledgmentssection.-Acknowledgments:IfyoulistanyonebynameintheAcknowledgmentssection,pleaseconfirmthatthepersongivespermissiontobenamed.-LicensetoPublish:Ifnotalreadysu

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論